Cargando…
Targeting Histone Deacetylases in Myeloid Cells Inhibits Their Maturation and Inflammatory Function With Limited Effects on Atherosclerosis
Monocytes and macrophages are key drivers in the pathogenesis of inflammatory diseases. Epigenetic targets have been shown to control the transcriptional profile and phenotype of these cells. Since histone deacetylase protein inhibitors demonstrate profound anti-inflammatory activity, we wanted to t...
Autores principales: | Luque-Martin, Rosario, Van den Bossche, Jan, Furze, Rebecca C., Neele, Annette E., van der Velden, Saskia, Gijbels, Marion J.J., van Roomen, Cindy P.P.A., Bernard, Sharon G., de Jonge, Wouter J., Rioja, Inmaculada, Prinjha, Rab K., Lewis, Huw D., Mander, Palwinder K., de Winther, Menno P.J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6830127/ https://www.ncbi.nlm.nih.gov/pubmed/31736752 http://dx.doi.org/10.3389/fphar.2019.01242 |
Ejemplares similares
-
BET Inhibition Improves NASH and Liver Fibrosis
por: Middleton, Sarah A., et al.
Publicado: (2018) -
Classic and new mediators for in vitro modelling of human macrophages
por: Luque‐Martin, Rosario, et al.
Publicado: (2020) -
Targeting macrophage Histone deacetylase 3 stabilizes atherosclerotic lesions
por: Hoeksema, Marten A, et al.
Publicado: (2014) -
Epigenetic modulation of type-1 diabetes via a dual effect on pancreatic macrophages and β cells
por: Fu, Wenxian, et al.
Publicado: (2014) -
Peritoneal macrophages have an impaired immune response in obesity which can be reversed by subsequent weight loss
por: Willemsen, Lisa, et al.
Publicado: (2019)